Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies
- PMID: 38249528
- PMCID: PMC10796818
- DOI: 10.3389/fncel.2023.1328269
Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies
Abstract
Over the last few decades, emerging evidence suggests that non-coding RNAs (ncRNAs) including long-non-coding RNA (lncRNA), microRNA (miRNA) and circular-RNA (circRNA) contribute to the molecular events underlying progressive neuronal degeneration, and a plethora of ncRNAs have been identified significantly misregulated in many neurodegenerative diseases, including Parkinson's disease and synucleinopathy. Although a direct link between neuropathology and causative candidates has not been clearly established in many cases, the contribution of ncRNAs to the molecular processes leading to cellular dysfunction observed in neurodegenerative diseases has been addressed, suggesting that they may play a role in the pathophysiology of these diseases. Aim of the present Review is to overview and discuss recent literature focused on the role of RNA-based mechanisms involved in different aspects of neuronal pathology in Parkinson's disease and synucleinopathy models.
Keywords: Parkinson’s disease; circRNA; dopamine neurons; lncRNA; miRNA; ncRNA; synucleinopathy; α-synuclein.
Copyright © 2024 Meccariello, Bellenchi, Pulcrano, D’Addario, Tafuri, Mercuri and Guatteo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision. The handling editor VG declared a past co-authorship with the author NBM.
Figures
Similar articles
-
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.Brain. 2020 Dec 1;143(12):3717-3733. doi: 10.1093/brain/awaa269. Brain. 2020. PMID: 33118032
-
Emerging roles of non-coding RNAs in retinal diseases: A review.Clin Exp Ophthalmol. 2020 Nov;48(8):1085-1101. doi: 10.1111/ceo.13806. Epub 2020 Jul 1. Clin Exp Ophthalmol. 2020. PMID: 32519377 Review.
-
Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases.J Biomed Sci. 2020 Apr 7;27(1):49. doi: 10.1186/s12929-020-00636-z. J Biomed Sci. 2020. PMID: 32264890 Free PMC article. Review.
-
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.Front Aging Neurosci. 2022 Aug 9;14:975248. doi: 10.3389/fnagi.2022.975248. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36016854 Free PMC article. Review.
-
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.Front Oncol. 2023 Sep 8;13:1256537. doi: 10.3389/fonc.2023.1256537. eCollection 2023. Front Oncol. 2023. PMID: 37746261 Free PMC article. Review.
Cited by
-
Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.Front Cell Neurosci. 2024 Jul 26;18:1429977. doi: 10.3389/fncel.2024.1429977. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39131043 Free PMC article. Review.
-
Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness.Int J Mol Sci. 2024 Aug 29;25(17):9407. doi: 10.3390/ijms25179407. Int J Mol Sci. 2024. PMID: 39273354 Free PMC article. Review.
-
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges.J Nanobiotechnology. 2025 Jun 18;23(1):453. doi: 10.1186/s12951-025-03528-2. J Nanobiotechnology. 2025. PMID: 40533746 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources